IBM’s Watson will team up with Memorial Sloan Kettering this fall and plans to launch in a handful of cancer care centers this year, but Dan Cerutti, IBM’s GM of Watson Commercialization, said today at GigaOM Structure that Watson could be used in other fields too. [...]
A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors...
A study by Travis H. Stracker, researcher at the Institute for Research in Biomedicine (IRB Barcelona), in collaboration with scientists at the Memorial Sloan Kettering Cancer Center (MSKCC) in New York, reveals new information about the origin of tumors. read more
Gustin L. Reichbach: This is not a law-and-order issue; it is a medical and a human rights issue. Being treated at Memorial Sloan Kettering Cancer Center, I am receiving the absolute gold standard of medical care. But doctors cannot be expected to do what the law prohibits, even when they know it is in the best interests of their patients. Show More Summary
For a computer, Watson gets some enviable gigs. Starting this week, ‘s Jeopardy-playing supercomputer is going to school at ‘s Memorial Sloan Kettering Cancer Center, where clinicians at the elite research hospital will begin “teaching” the computer to review oncological case histories and come up with the right treatments. The two organizations, and MSKCC, [...]
In the March 8 issue of the New England Journal of Medicine, a team of researchers at Memorial Sloan Kettering Cancer Center report on an extremely rare phenomenon known as the abscopal effect, in cancer patients with melanoma, treated with the immunotherapeutic agent ipilimumab (Yervoy™). Show More Summary
On March 27th, 2011, we learned the unthinkable: our 2 1/2 year old granddaughter, Emma Zinberg, had cancer. Within 24 hours, she was a patient at Memorial Sloan Kettering Cancer Center. While we had received an initial diagnosis of neuroblastoma at the hospital that found her tumor, the team of oncologists and surgeons at MSKCC [...]
Errant Gene Therapeutics, LLC ("EGT"), a pioneering boutique drug development firm specializing in Rare Diseases, announced the transfer of its clinical grade lentiviral vector, TNS 9.55.3, to Memorial Sloan Kettering Cancer Center ("MSKCC"). Show More Summary
At NYC’s Memorial Sloan Kettering Cancer Center, acupuncture is been used to treat breast cancer and is showing remarkable promise. We’re using acupuncture to encourage her body to a better water metabolism and open up a different pathway for the redistribution of the fluid in her body,” said Dr. Yi Hung Chan, DPM of Memorial Sloan [...]Show More Summary
New studies in prostrate cancer screening reveal conflicting views about the importance of getting men tested for the disease. Research headed by Hans Lilja at the Memorial Sloan Kettering Medical Center suggests that a single test for prostate specific antigen (PSA) given at age 60 could accurately predict mortality from prostate cancer. 90% of deaths [...]
GE Healthcare, a unit of General Electric Company (NYSE:GE), announced the installation of two new Optima™ MR450w wide bore magnetic resonance imaging systems at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City. The first...Show More Summary
In the February 1st issue of G&D, Dr. Johanna Joyce and colleagues at Memorial Sloan Kettering Cancer Center lend new insight into the mechanism by which tumor-associated macrophages promote malignant progression. The paper will be made available online ahead of print at http:// www.genesdev.org. Show More Summary
Have you ever witnessed an employee whose personal identity is closely connected to the identity of his or her organization? I’ve written about Nick the doorman at Memorial Sloan Kettering Cancer Center (MSKCC) in New York City and how fired up he is greeting cancer patients and their families. Nick actually begins making eye contact [...]
UroToday.com - In the February issue of the Journal of Urology, a group from Memorial Sloan Kettering Cancer Center tested the European Society of Urological Oncology (ESUO) recommendation that the seminal vesicles may not need to be removed at the time of radical prostatectomy (RP). Show More Summary
Lung cancer is the leading cause of cancer-related death in the US and worldwide. Most patients who develop lung cancer have a history of smoking cigarettes. However, about 1 in 10 lung cancer patients has no history of direct tobacco exposure. Show More Summary
A study of almost 1,500 kidney cancer patients treated at Memorial Sloan Kettering Cancer Center suggests that surgery to spare as much kidney tissue as possible may improve overall survival in patients who also have reduced kidney function at the time their cancer is diagnosed. Show More Summary
BERLIN, GERMANY (UroToday.com) - Dr. Farhang Rabbani, Attending Surgeon, Memorial Sloan Kettering Cancer Center (MSKCC), presented a comprehensive review of the complications associated with radical prostatectomy.
The band exclaims: All donations go to Memorial Sloan Kettering Cancer Center in honor of Luca Vasallo, a friend to the band and a current patient who is seven months old and doing a great job fighting a very difficult disease. This is a very good organization that certainly deserves the attention. Show More Summary
Ever wonder how a charity benefit comes together? With plenty of hard work -- and goosebumps. A report from a planning session for the Society of Memorial Sloan Kettering Cancer Center’s spring ball.